PARMAR VINENDRA M and GOSWAMI SUNITA S 2019. EFFICACY AND SAFETY OF TENELIGLIPTIN AS ADD-ON THERAPY TO CONVENTIONAL THERAPY IN INDIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Asian Journal of Pharmaceutical and Clinical Research. 12, 12 (Dec. 2019), 116–120. DOI:https://doi.org/10.22159/ajpcr.2019.v12i12.35952.